Healing

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development

Retrieved on: 
Tuesday, February 1, 2022

Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the companys CBD pharmaceutical and nutraceutical development strategy.

Key Points: 
  • Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the companys CBD pharmaceutical and nutraceutical development strategy.
  • PAOG has positioned itself as an emerging CBD Biopharma company on a development path to treat various and major respiratory diseases that represent billions in potential market sizes.
  • PAOG has also recently announced the development of a new line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) now underway.
  • PAOG also expects to make a strategic announcement with PURA regarding a new partnership on CBD nutraceutical production resources.

PAOG Publishes 2022 Strategic Update

Retrieved on: 
Friday, January 28, 2022

Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the companys CBD pharmaceutical and nutraceutical development strategy.

Key Points: 
  • Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the companys CBD pharmaceutical and nutraceutical development strategy.
  • The update is included in its entirety below:
    PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks pharmaceutical and nutraceutical.
  • PAOG has positioned itself as an emerging CBD Biopharma company on a development path to treat various and major respiratory diseases that represent billions in potential market sizes.
  • PAOG also expects to make a strategic announcement with PURA regarding a new partnership on CBD nutraceutical production resources.

New Business Takes On Epidemic of Poor Posture and Spine Disorders

Retrieved on: 
Monday, January 24, 2022

BOISE, Idaho, Jan. 24, 2022 /PRNewswire-PRWeb/ --A brand new chiropractic clinic and spine rehab facility, Optimal Spine & Posture, is now open and serving the Boise, ID communities.

Key Points: 
  • BOISE, Idaho, Jan. 24, 2022 /PRNewswire-PRWeb/ --A brand new chiropractic clinic and spine rehab facility, Optimal Spine & Posture, is now open and serving the Boise, ID communities.
  • Optimal Spine & Posture not only specializes in posture, but an array of spine disorders including low back pain, neck pain, headaches and migraines, hyperkyphosis and scoliosis.
  • The team at Optimal Spine & Posture is led by Dr. Justin Anderson, D.C. who is an advanced certified Chiropractic Biophysics clinician and diplomate.
  • Optimal Spine & Posture is the trusted leader in spine correction, an innovative force, where chiropractic meets advanced spine correction.

Pastor Alph Lukau's revolutionary book crosses the million mark worldwide

Retrieved on: 
Friday, January 7, 2022

DALLAS, Jan. 7, 2022 /PRNewswire/ -- The transformative book "The Rise of the Prophetic Voice" has crossed more than 3 million copies in sales worldwide, as per AMI USA.

Key Points: 
  • DALLAS, Jan. 7, 2022 /PRNewswire/ -- The transformative book "The Rise of the Prophetic Voice" has crossed more than 3 million copies in sales worldwide, as per AMI USA.
  • The book is said to have transformed the lives of millions of people across the globe.
  • Pastor Alph Lukau truly believes that irrespective of any situation, God's unwavering love is heartening and is guiding those who believe in him in the fulfilling of their destiny.
  • My message to mankind has been delivered well," said the euphoric author Pastor Alph Lukau .

National AIDS Memorial Honors History-Making Television Series Pose for Connecting a New Generation to the Story of AIDS and the Long Struggle for Health and Social Justice

Retrieved on: 
Wednesday, December 1, 2021

"Pose has had a far-reaching impact in helping bring the story of AIDS and the long struggle for health and social justice to the forefront through its brilliant and authentic storytelling," said National AIDS Memorial CEO John Cunningham.

Key Points: 
  • "Pose has had a far-reaching impact in helping bring the story of AIDS and the long struggle for health and social justice to the forefront through its brilliant and authentic storytelling," said National AIDS Memorial CEO John Cunningham.
  • One particularly touching storyline from Pose connected directly to the work of the National AIDS Memorial.
  • The National AIDS Memorial is looked upon as the organization within the national landscape to remember, honor and help ensure the stories of the AIDS pandemic and the AIDS Movement are never forgotten.
  • To learn more the mission and programs of the National AIDS Memorial, the World AIDS Day Virtual Observance, and to watch all the conversation series, visit www.aidsmemorial.org .

ChiliSleep, Grey Team Partner to Improve Sleep Quality for Veterans Suffering the Invisible Wounds of War

Retrieved on: 
Monday, November 8, 2021

The study will examine the role that sleep plays in improving veterans' bodies and minds using the ChiliSleep system.

Key Points: 
  • The study will examine the role that sleep plays in improving veterans' bodies and minds using the ChiliSleep system.
  • Because were veterans ourselves, were able to empathize with the complex issues that can develop, said Cary Reichbach, Founder of Grey Team.
  • Donating an additional 10 Cube sleep systems for veterans to take home and use to improve their deep sleep and wellness during their time with Grey Team.
  • ChiliSleep is building awareness for quality sleep as a meaningful tool to fight PTSD and other health challenges facing veterans.

TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash

Retrieved on: 
Monday, November 1, 2021

Additionally, TELA Bio received a first right of negotiation for the EU market upon successful CE approval.

Key Points: 
  • Additionally, TELA Bio received a first right of negotiation for the EU market upon successful CE approval.
  • "We are excited to work with Next Science and will commence private label marketing of the solution for plastic surgery in early 2022," said Antony Koblish, President and CEO of TELA Bio.
  • Commenting on the agreement, Judith Mitchell, CEO of Next Science Limited said, "We are delighted to expand our commercial footprint through the TELA Bio sales organization.
  • TELA Bio goes to market through a direct sales force to service the US plastics market.

A Safe Haven's President and Co-Founder Neli Vazquez Rowland Shares Her Story in Microsoft's Legacy Project: Hispanic and Latinx Heritage Edition

Retrieved on: 
Tuesday, September 28, 2021

Vazquez Rowland is a first-generation American of Mexican heritage with humble beginnings but with big dreams to help others.

Key Points: 
  • Vazquez Rowland is a first-generation American of Mexican heritage with humble beginnings but with big dreams to help others.
  • For more information about the Microsoft Legacy Project: Hispanic Latinx Heritage Edition, visit this link .
  • In this new Legacy Project "Hispanic & Latinx Edition" exhibit we are recognizing legacies, achievements, and the strength of Hispanic and Latinx communities.
  • A Safe Haven's visible social and economic impact unites families, stabilizes neighborhoods, and creates vibrant, viable communities.

InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment

Retrieved on: 
Monday, July 26, 2021

This newly-released research paper, titled First Immunohistochemical Evidence of Human Tendon Repair Following Stem Cell Injection: A Case Report and Review of Literature , was published in the World Journal of Stem Cells on July 23, 2021 (DOI: https://dx.doi.org/10.4252/wjsc.v13.i7.944 ).

Key Points: 
  • This newly-released research paper, titled First Immunohistochemical Evidence of Human Tendon Repair Following Stem Cell Injection: A Case Report and Review of Literature , was published in the World Journal of Stem Cells on July 23, 2021 (DOI: https://dx.doi.org/10.4252/wjsc.v13.i7.944 ).
  • The analysis strongly indicates regenerative healing of the tendon, resulting from transformation of UA-ADRCs into new tendon tissue.
  • Importantly, the investigated tendon showed evidence of histological regeneration without scar formation, a finding indicating significant advantages over existing treatments options.
  • The microscopic images of the tendon treated with stem cells clearly demonstrate that a different type of healing had taken place.

Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

Retrieved on: 
Thursday, July 22, 2021

Dr Sorensen brings a wealth of patient-centred R&D experience in many therapeutic areas including thrombosis and hemostasis.

Key Points: 
  • Dr Sorensen brings a wealth of patient-centred R&D experience in many therapeutic areas including thrombosis and hemostasis.
  • The pipeline will initially focus on underserved people living with rare bleeding disorders such asGlanzmann's Thrombasthenia (GT), with plans to expand intomore common disorders of hemostasis and thrombosis.
  • Jrgen Sberg Petersen, Partner at Novo Holdings, and Camilla Petrycer Hansen, Principal at Novo Seeds will continue as Chairman and Independent Director on the Board.
  • Hemab is an emerging biotech company developing next generation therapeutics for serious, underserved bleeding and thrombosis disorders.